Assenagon Asset Management S.A. Cerus Corp Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

A detailed history of Assenagon Asset Management S.A. transactions in Cerus Corp stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 1,257,571 shares of CERS stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,257,571

Previous 1,186,564 5.98%

Holding current value

$2.25 Million

Previous $2.09 Million 4.79%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$1.7 - $2.39 $120,711 - $169,706	71,007 Added 5.98%	1,257,571 $2.19 Million
Q2 2024 Jul 18, 2024	BUY	$1.62 - $2.04 $127,694 - $160,800	78,824 Added 7.12%	1,186,564 $2.09 Million
Q1 2024 Apr 24, 2024	BUY	$1.66 - $2.42 $943,057 - $1.37 Million	568,107 Added 105.28%	1,107,740 $2.09 Million
Q4 2023 Jan 17, 2024	BUY	$1.25 - $2.35 $159,832 - $300,485	127,866 Added 31.05%	539,633 $1.17 Million
Q3 2023 Nov 06, 2023	BUY	$1.5 - $3.07 $475,834 - $973,874	317,223 Added 335.53%	411,767 $667,000
Q2 2023 Jul 25, 2023	SELL	$1.79 - $2.9 $780,636 - $1.26 Million	-436,110 Reduced 82.18%	94,544 $232,000
Q1 2023 Apr 18, 2023	SELL	$2.65 - $3.81 $5.22 Million - $7.51 Million	-1,970,657 Reduced 78.78%	530,654 $1.58 Million
Q4 2022 Jan 12, 2023	BUY	$3.38 - $4.22 $32,387 - $40,436	9,582 Added 0.38%	2,501,311 $9.13 Million
Q3 2022 Oct 27, 2022	SELL	$3.43 - $5.83 $1.7 Million - $2.88 Million	-494,763 Reduced 16.57%	2,491,729 $8.97 Million
Q2 2022 Jul 27, 2022	BUY	$4.41 - $5.69 $11.9 Million - $15.3 Million	2,695,901 Added 927.73%	2,986,492 $15.8 Million
Q1 2022 Apr 25, 2022	BUY	$4.81 - $6.99 $846,800 - $1.23 Million	176,050 Added 153.7%	290,591 $1.6 Million
Q2 2021 Jul 15, 2021	BUY	$5.35 - $6.35 $612,794 - $727,335	114,541 New	114,541 $677,000

Others Institutions Holding CERS

# of Institutions

156

Shares Held

147M

Call Options Held

84.2K

Put Options Held

55.5K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Cerus Corp Transaction History